San Diego Life Sciences Roundup: MedCrypt, LunaDNA, Dynacure & More

Xconomy

Let’s catch up with the latest life sciences news in San Diego. “Patient data privacy has long been a concern, but the healthcare industry is just beginning to address patient safety risks presented by internet-connected healthcare technology,” Read more » Reprints | Share: UNDERWRITERS AND PARTNERS. — Cybersecurity company MedCrypt, which makes software to protect medical devices, raised a $5.3 million Series A funding round.

Back to the (Near) Future: Join Us for San Diego Life Sciences 2022

Xconomy

In 2010, Xconomy convened “San Diego Life Sciences 2030,” a séance with the soothsayers of San Diego as they gazed into the future at what the local life sciences landscape might look like 20 years from now.

ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight

Xconomy

Data presented at the American Society of Clinical Oncology meeting each year can change medical practice and make or break companies whose drugs are under the microscope. The world’s biggest annual cancer conference is just around the corner.

At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments

Xconomy

The first new class of migraine drugs in decades won FDA approval last year.

Class 90

New U.S. “Roadmap” Lays Out Routes to Accelerate Robotic Technologies

Xconomy

Christensen made his observations during a presentation at the 2016 Contextual Robotics Forum, a recent conference at UC San Diego focused this year on “new directions in human-machine interaction.”.

Bio Roundup: Pharma in D.C., Bristol-Cel in Trouble, Roche Gets A Spark

Xconomy

Bristol (NYSE: BMY ) and Celgene (NASDAQ: CELG ) have campaignned heavily, starting with a joint presentation by their CEOs at the J.P. Could a shareholder revolt doom the planned marriage of Bristol-Myers Squibb and Celgene?

Exosomes Head to Wall Street As Codiak Biosciences Lines Up IPO

Xconomy

The coming IPO for Codiak Biosciences will present a test case. Do Wall Street investors believe that exosomes, the tiny bubbles once thought to be just cellular garbage bins, may be the key to treating a slew of potential diseases?

California Accelerators Enroll Startups Targeting Cannabis Industry

Xconomy

On Monday, nine startups began a 16-week program at Canopy San Diego , a new accelerator program for seed-stage companies developing new technologies, products, and services to support the legal cannabis industry.

Bio Roundup: Depression Drug Dashed, Peek at ASH, CRISPR Worry & More

Xconomy

We also bring you a few verses from the abstract , er, abstracts: Previews of results that will be presented more. The gene-editing technology CRISPR-Cas9 is opening up new research avenues all the time, such as giving drug developers a cheaper, faster way to knock out genes in tumor cells. Studies of CRISPR-Cas9 to treat human disease are about to start, too.

Tocagen Adopts “Seamless Pivotal Trial” for Brain Cancer Therapy

Xconomy

Yet San Diego-based Tocagen (NASDAQ: TOCA ) says five patients in a high-dose cohort of its gene therapy treatment Toca 511 and Toca FC are still alive after nearly 36 months.

Notes From the JPM ’18 Vortex: Gene Therapy’s Reckoning and Lonely Cabs

Xconomy

Morgan Healthcare conference in San Francisco winds down today, meaning the remaining stragglers are either presenting to half-empty rooms or headed back to colder climes. The annual J.P.

Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts

Xconomy

At one of the year’s big cancer meetings, investors, researchers, and many others will have a close eye on a group of presentations touting new lung cancer regimens that combine immunotherapies with other treatments.

Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets

Xconomy

For most patients—and for many drug developers—healthcare reimbursement policies can present a daunting maze of restrictions and uncertainties.

Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests?

Xconomy

Cancer experts believe that the data the company is presenting this morning at the American Society of Clinical Oncology not only demonstrate the potential of one.

Help 81

Wind Startup Evokes Puerto Rico’s Plight, Wins EvoNexus Pitch Event

Xconomy

San Diego’s Uprise Energy won the audience vote for best presentation at EvoNexus Demo Day, with a pitch that highlighted how its mobile wind turbines could help alleviate the plight of Puerto Rico in the wake of Hurricane Maria’s apocalyptic devastation. The startup event drew more than 400 people to Qualcomm’s San Diego headquarters late Thursday. National blog main National top stories San Diego San Diego blog main San Diego top stories

Echo Labs Wins “Quick Pitch” Contest with Digital Hybrid Microscope

Xconomy

By popular acclaim, San Diego-based Echo Laboratories founder Eugene Cho claimed top honors, and a $15,000 check, for his two-minute presentation last week in the 10th annual “Quick Pitch” competition, hosted by San Diego’s Tech Coast Angels.

Connect Hands Out 8 Most Innovative New Product Awards

Xconomy

Connect, the San Diego nonprofit supporting local innovation and entrepreneurship, handed out its Most Innovative New Product Awards at a dinner last night in La Jolla—recognizing innovations that range from an inflatable satellite antenna to a mobile app for art museums. The list was winnowed to about 30 finalists who presented their products last month to a panel of judges seleecting the winner in each category.

Organovo to Test “Patches” for Patients Awaiting Liver Transplants

Xconomy

San Diego-based Organovo (NASDAQ: ONVO ) said today it plans to use its 3D bio-printing technology to produce living human liver tissue “patches” that can be transplanted in patients with fatal liver disease. The conference is making a webcast of his presentation available here.

Sample 108

A16Z Bio Fund’s Pande Sees A.I. as Way to Ride Bio Innovation

Xconomy

In a presentation a few months ago at the firm’s annual a16z Summit , Pande argued that many aspects of biology (biochemical pathways, for example) have become so big, complicated, and messy that understanding the system is beyond what a human being can comprehend.

All In One Place: A New Immuno-Oncology Trial Resource

Xconomy

We acknowledge that what we present here only scratches the surface of each trial. More than 100 years ago, New York bone surgeon William Coley began to suspect that bacterial infections might be improving the outlook for patients also suffering from cancer.

Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout

Xconomy

But yeah, that happened to Loxo Oncology when it released data previews for its American Society for Clinical Oncology presentations; the meeting starts in two weeks in Chicago. There’s nothing abstract about a 20 percent jump in a company’s stock price. Wednesday was ASCO abstract day, and we’ll round up the headliners below, all with caveats that these early peeks are not peer-reviewed and could be updated in a couple weeks.

ASH Sneak Peeks: Novartis, Juno Update CAR-T Lymphoma Competition

Xconomy

But previews of the big data presentations are out today, yielding more insight into what promises to be the first major competition in CAR-T cell therapy: Treatments for people with non-Hodgkin lymphoma (NHL) who have run out of other options and likely have only a few months to live.

Water Metering Startup Wins Vote for “Best Demo” at EvoNexus Event

Xconomy

A San Diego civil engineer who has developed an alternative technology for automating the measurement of water flow gave the best presentation at EvoNexus Fall Demo Day, an event that drew nearly 400 entrepreneurs, investors, and supporters late Thursday to Qualcomm’s corporate headquarters. Water Pigeon co-founder Sarp Sekeroglu got the most votes in a survey conducted immediately after six startups incubating at EvoNexus gave short presentations.

Ionis, Biogen Make History With FDA Nod for Spine Disease Drug

Xconomy

Patients with spinal muscular atrophy got an early Christmas present on Friday. The FDA approved nusinersen (Spinraza), making the drug the first-ever marketed treatment for the rare, potentially deadly genetic disorder.

Agenda Posted for Xconomy’s Human Impact of Innovation on April 19

Xconomy

We have posted the agenda for Human Impact of Innovation , which happens on April 19 at The Illumina Theater at the Alexandria Torrey Pines in San Diego.

Uber Suspends Driverless Testing After Fatal Accident in Arizona

Xconomy

The ride-hailing giant has suspended testing on driverless cars in Arizona, Pittsburgh, San Francisco, and Toronto, according to the New York Times. The inevitable has happened. An autonomous Uber car hit a pedestrian in Tempe, AZ, and caused her death.

Tyler Jacks, Cancer Moonshot Panel Co-Chair, Discusses Roadmap

Xconomy

This week, a panel of 28 scientists presented the National Cancer Institute’s National Cancer Advisory Board a set of recommendations and national priorities for basic research, clinical trial practice, and drug development.

Mobileye Sets Safety-Based Rules of the Road for Self-Driving Tech

Xconomy

Defining just what constitutes “safe driving” for self-driving cars was the primary focus of a presentation Shashua delivered earlier this month at the Intel Capital Global Summit. It’s been a busy year for Jerusalem-based Mobileye since Intel (NASDAQ: INTC ) completed its $15.3-billion acquisition of the Israeli specialist in autonomous navigation technology. In a recent update, Mobileye co-founder and CTO Amnon Shashua said the company has almost doubled its workforce since the buyout.

CTO 44

Procrastinators’ Special! Save on 4/19 Human Impact of Innovation

Xconomy

We’re hosting an afternoon of insightful presentations and candid chats about some innovations that are making the biggest impact on human lives. Our program includes leading innovators, startup founders, investors, scientists, and CEOs from San.

Esports Startup Cayke Wins Audience Vote at EvoNexus Demo Day

Xconomy

Cayke, a San Diego startup that has developed video editing software to automate the process of creating GIFs and highlight clips from long-running video game streams, was the top vote-getter of seven startups that presented at the EvoNexus Spring Demo Day.

At Big Hemophilia Meeting, More Data, and Promise, For Gene Therapy

Xconomy

With that, here are the latest updates from the gene therapy players to present at the WFH’s meeting this week.

Organovo to Test Pre-Clinical Drugs on Bio-Printed Kidney Tissue

Xconomy

Since then, the San Diego company has built a thriving business as a contract research organization (CRO) that tests experimental drug compounds on bio-printed liver tissue. Turnout for Organovo presentation at Society of Toxicology Meeting in March (photo courtesy of Organovo).

As Drone Navigation Advances, SlantRange Focuses on Farm Analytics

Xconomy

For example, at Xconomy’s Robo Madness forum in San Jose, CA, last month, three companies each presented a different approach to intelligent navigation: — PreNav , founded in San Carlos, CA, in 2013, has developed a separate, ground-based system that uses a pulsed laser (formally known as Light Detection and Ranging, or LIDAR) to precisely determine the flight path for a quadcopter.

Guide 62

Xconomy Award Finalists In The Eye Of the National Drug Price Debate

Xconomy

It’s no surprise, then, that several finalists for the first Xconomy Awards , to be presented September 26 in. The national debate over the high cost of healthcare, with prescription drugs at the center, resonates from the chambers of Congress to every American’s pocketbook.

New Data Show Biogen, Ionis Drug Might Help More With Rare Spine Disease

Xconomy

More data will be presented at a future medical meeting. Up until this point, studies of an experimental drug from Biogen and Ionis Pharmaceuticals had focused on patients with the most severe form of a rare, potentially deadly genetic disorder called spinal muscular atrophy.

Study 98